38 reports

  • Infectious Diagnostics Market, United Kingdom, Company Share (%) 2017
  • Mycobacterium tuberculosis Diagnostic Tests Market, United Kingdom, Volume (Units), Forecast,

ONE UNIT REFERS TO ONE TEST.

  • Diagnostics
  • Northern Europe
  • Alere Inc.
  • Beckman Coulter, Inc.
  • QIAGEN N.V.

Rationale The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, IT and laboratory automation will radically change the global coagulation

  • Coagulation Diagnostic
  • Diagnostics
  • Latin America
  • Northern Europe
  • Demand

Infectious Disease Screening Tests AIDS (HIV NAT, HIV-##/ ##), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/ SGPT), HTLV-I/ II, Parvovirus B## NAT, Syphilis, West Nile Virus NAT.

  • Diagnostics
  • Australasia
  • Northern Europe
  • Demand
  • Forecast

2018 Europe Diagnostics Market Forecasts 2018 Europe Diagnostics Market Forecasts for ## Tests: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular

  • Cancer Diagnostics
  • Diagnostics
  • Baltics
  • Europe
  • Northern Europe

2019 Europe Diagnostics Market Forecasts for ## Tests 2019 Europe Diagnostics Market Forecasts for ## Tests: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Mo

  • Cancer Diagnostics
  • Diagnostics
  • Northern Europe
  • Forecast
  • Market Size

Infectious Disease Screening Tests AIDS (HIV NAT, HIV-##/ ##), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/ SGPT), HTLV-I/ II, Parvovirus B## NAT, Syphilis, West Nile Virus NAT.

  • Diagnostics
  • Infectious Disease
  • Northern Europe
  • Demand
  • Forecast

Rationale The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, IT and laboratory automation will radically change the global coagulation

  • Coagulation Diagnostic
  • Diagnostics
  • In Vitro Diagnostic Reagent
  • In Vitro Diagnostics
  • Northern Europe
  • Norway - Cervical Cancer HPV DNA Test Population (Thousand), 2011 - 2017
  • 14.1.2 Norway Cervical Cancer HPV DNA Test Population & Forecast

The result could be obtained back within one hour.

  • Diagnostics
  • Northern Europe
  • World
  • Demographic
  • Forecast

New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays.

  • Diagnostics
  • Medical Biotechnology
  • North America
  • Northern Europe
  • World

The test was used mainly for diagnostic purposes rather than for cervical cancer screening and available for screening on a demand basis.

  • Cancer Diagnostics
  • Diagnostics
  • Sexually Transmitted Disease
  • Northern Europe
  • Forecast

Rationale The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, IT and laboratory automation will radically change the global coagulation

  • Diagnostics
  • In Vitro Diagnostic Reagent
  • Australasia
  • Northern Europe
  • Demand

Infectious Disease Screening Tests AIDS (HIV NAT, HIV-##/ ##), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/ SGPT), HTLV-I/ II, Parvovirus B## NAT, Syphilis, West Nile Virus NAT.

  • Diagnostics
  • Infectious Disease
  • Pathology
  • Northern Europe
  • Demand

Contains ##, ## pages and ## tables Companies Profiled Competitive Assessments - Abbott - Beckman Coulter/ Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio - Grifols - Hologic - Immucor - LabCorp - Ortho-Clinical Diagnostics - Proteome Science

  • Diagnostics
  • Infectious Disease
  • Baltics
  • Northern Europe
  • Demand

Instrumentation Review - Analysis of major molecular diagnostic and immunodiagnostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.

  • Cancer Diagnostics
  • Diagnostics
  • Medical Biotechnology
  • Baltics
  • Northern Europe

Rationale The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, IT and laboratory automation will radically change the global coagulation

  • Diagnostics
  • In Vitro Diagnostic Reagent
  • Northern Europe
  • Scandinavia
  • Demand

Ultrasound is generally recommended as a secondary diagnostic tool in Canada.

  • Breast Cancer
  • Diagnostics
  • Northern Europe
  • Southeast Asia
  • Forecast

New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays.

  • Diagnostics
  • Medical Biotechnology
  • Baltics
  • Northern Europe
  • Demand

Ultrasound is generally recommended as a secondary diagnostic tool in Canada.

  • Breast Cancer
  • Diagnostics
  • Northern Europe
  • Forecast
  • Social Conditions

Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

  • Diagnostics
  • APAC
  • Australasia
  • North America
  • Northern Europe

Rationale The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, IT and laboratory automation will radically change the global coagulation

  • Coagulation Diagnostic
  • Diagnostics
  • In Vitro Diagnostic Reagent
  • In Vitro Diagnostics
  • Northern Europe
  • 14.1.2 Norway Cervical Cancer HPV DNA Test Population & Forecast
  • Norway - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015

These points have been further sub ##.

  • Diagnostics
  • Northern Europe
  • World
  • Demographic
  • Forecast

It now represents one in four of all cancers in women.

  • Breast Cancer
  • Diagnostics
  • Northern Europe
  • Forecast
  • Social Conditions

Infectious Disease Screening Tests AIDS (HIV NAT, HIV-##/ ##), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/ SGPT), HTLV-I/ II, Parvovirus B## NAT, Syphilis, West Nile Virus NAT.

  • Diagnostics
  • Infectious Disease
  • Northern Europe
  • Demand
  • Forecast

Rationale The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, IT and laboratory automation will radically change the global coagulation

  • Diagnostics
  • In Vitro Diagnostic Reagent
  • In Vitro Diagnostics
  • Baltics
  • Northern Europe

Contains ## pages and ## tables Companies Profiled Competitive Assessments - Abbott - Beckman Coulter/ Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Diagast - DiaSorin - Fujirebio - Grifols - Hologic - Immucor - LabCorp - Ortho-Clinical Diagnostics - Proteome Sciences

  • Diagnostics
  • Infectious Disease
  • Northern Europe
  • Demand
  • Forecast

Infectious Disease Screening Tests AIDS (HIV NAT, HIV-##/ ##), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/ SGPT), HTLV-I/ II, Parvovirus B## NAT, Syphilis, West Nile Virus NAT.

  • Diagnostics
  • Infectious Disease
  • Pathology
  • Northern Europe
  • Scandinavia

Rationale The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, IT and laboratory automation will radically change the global coagulation

  • Coagulation Diagnostic
  • Diagnostics
  • In Vitro Diagnostic Reagent
  • In Vitro Diagnostics
  • Northern Europe

Ultrasound is generally recommended as a secondary diagnostic tool in Canada.

  • Diagnostics
  • Medical Device
  • Northern Europe
  • Forecast
  • Social Conditions
  • Norway - Cervical Cancer HPV DNA Test Population (Thousand), 2008 - 2015
  • 12.1.2 Norway Cervical Cancer HPV DNA Test Population & Forecast

Cervical Cancer Test Market, Population & Mortality ##.

  • Cancer Diagnostics
  • Cervical Cancer
  • Diagnostics
  • Northern Europe
  • Forecast
  • IMMUNO CHEMISTRY MARKET, UNITED KINGDOM, COMPANY SHARE BY REVENUE ($M), USD CONSTANT, 2017

ONE UNIT EQUALS TO ONE TEST.

  • Diagnostics
  • In Vitro Diagnostics
  • Northern Europe
  • Market Segment
  • F. Hoffmann-La Roche Ltd.